We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Health

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What Is Infliximab?

By B. Chisholm
Updated: May 17, 2024
Views: 7,434
Share

Infliximab is a tumor necrosis factor blocker. It is used in the treatment of a number of diseases, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease and ulcerative colitis. It is an injectable drug, and the dose and duration of treatment depends on the condition being treated. These conditions are due to an autoimmune process, which infliximab essentially blocks.

Infliximab is a monoclonal antibody that is thought to act by binding to the tumor necrosis factor alpha, which is a chemical messenger involved in the autoimmune process. Tumor necrosis factor alpha causes inflammation. By stopping the autoimmune reaction, infliximab may reduce the symptoms of these conditions to bring on and maintain remission. It does not, however, cure the disease.

Crohn's disease and ulcerative colitis are illnesses of the digestive tract often referred to as inflammatory bowel diseases. They can both cause severe discomfort and often diarrhea. Infliximab has been effective in some patients with these conditions in reducing the severity of symptoms and inducing and maintaining remission.

Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis are conditions that affect either the joints, spine or skin, sometimes in combination. Plaque psoriasis is a skin condition that causes red patches of scaly skin, or plaques, most commonly on the knees or elbows, but in some cases all over the body. They all result in significant inflammation and discomfort, linked to tumor necrosis factor alpha. Infliximab, by blocking the tumor necrosis factor alpha, can induce remission and maintain it. In the case of rheumatoid arthritis, infliximab is often used in combination with methotrexate when it is not effective on its own.

Administration of infliximab is by infusion, usually two treatments weekly for the first two doses, then a dose after four weeks, and then one treatment every eight weeks to maintain remission. The drug is normally administered in a hospital setting or in a doctor's room, as a hypersensitivity or allergic reaction may occur during or after administration, especially after the first two doses. Drugs to prevent this possible reaction may be given before the infliximab infusion is started.

As with any medication, infliximab may interact with other medications or conditions so these should be discussed with the prescribing doctor. Pregnancy, desired pregnancy or lactation should also be discussed. Adverse effects may occur, including susceptibility to infection, headache and hypersensitivity. These possible side effects should be discussed with the doctor, and should any untoward effect occur during or after treatment, medical attention should be sought immediately.

Share
WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Editors' Picks

Discussion Comments
Share
https://www.wisegeek.net/what-is-infliximab.htm
Copy this link
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.